Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Cannabis Cannabinoid Res ; 9(2): 537-546, 2024 Apr.
Article in English | MEDLINE | ID: mdl-36745386

ABSTRACT

Introduction: Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by neuroinflammation leading to demyelination. The associated symptoms lead to a devastating decrease in quality of life. The cannabinoids and their derivatives have emerged as an encouraging alternative due to their management of symptom in MS. Objective: The aim of the study was to investigate the mechanism of action of cannabidiol (CBD), a nonpsychoactive cannabinoid, on molecular and cellular events associated with leukocyte recruitment induced by experimental autoimmune encephalomyelitis (EAE). Materials and Methods: C57BL/6 female mice were randomly assigned to the four experimental groups: C (control group), CBD (cannabidiol-treated group, 5 mg/kg i.p.; 14 days), EAE (experimental autoimmune encephalomyelitis-induced group), and EAE+CBD (experimental autoimmune encephalomyelitis-induced plus cannabidiol-treated group). Results: The results indicated that 5 mg/kg of CBD injected intraperitoneally between the 1st and 14th days of EAE could reduce the leukocyte rolling and adhesion into the spinal cord microvasculature as well cellular tissue infiltration. These results were supported by a decreased mRNA expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in the spinal cord. Conclusion: Purified CBD reduces in vivo VCAM and ICAM-mediated leukocyte recruitment to the spinal cord microvasculature at EAE peak disease.


Subject(s)
Cannabidiol , Cannabinoids , Encephalomyelitis, Autoimmune, Experimental , Multiple Sclerosis , Animals , Mice , Female , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Cannabidiol/adverse effects , Quality of Life , Mice, Inbred C57BL , Spinal Cord , Cannabinoids/adverse effects , Leukocytes , Microvessels
2.
Front Cell Neurosci ; 16: 921916, 2022.
Article in English | MEDLINE | ID: mdl-36052340

ABSTRACT

Dysregulated microglia and astrocytes have been associated with progressive neurodegeneration in multiple sclerosis (MS), highlighting the need for strategies that additionally target intrinsic inflammation in the central nervous system (CNS). The objective of the present study was to investigate the glial response in experimental autoimmune encephalomyelitis (EAE)-induced mice treated with a combination of dimethyl fumarate (DMF) and pregabalin (PGB). For that, 28 C57BL/6J mice were randomly assigned to the five experimental groups: naïve, EAE, EAE-DMF, EAE-PGB, and EAE-DMF + PGB. Pharmacological treatments were initiated with the beginning of clinical signs, and all animals were euthanized at 28 dpi for the lumbar spinal cord evaluation. The results demonstrated a stronger attenuation of the clinical presentation by the combined approach. DMF alone promoted the downregulation of Iba-1 (microglia/macrophages marker) in the ventral horn compared with the non-treated EAE animals (P < 0.05). PGB treatment was associated with reduced Iba-1 immunofluorescence in both the dorsal (P < 0.05) and ventral horn (P < 0.05) compared to EAE vehicle-treated counterparts. However, the combined approach reduced the Iba-1 marker in the dorsal (P < 0.05) and ventral (P < 0.01) horns compared to non-treated EAE animals and further reduced Iba-1 in the ventral horn compared to each drug-alone approach (P < 0.05). In addition, the combination of DMF and PGB reduced activated astrocytes (GFAP) in both the dorsal and ventral horns of the spinal cord to a naïve-like level and upregulated Nrf-2 expression. Taken together, the data herein suggest robust attenuation of the glial response in EAE mice treated with DMF and PGB.

3.
Brain Res Bull ; 164: 184-197, 2020 11.
Article in English | MEDLINE | ID: mdl-32866558

ABSTRACT

CNS lesions usually result in permanent loss of function and are an important problem in the medical field. In order to investigate neuroprotection/degeneration mechanisms and the synaptic plasticity of motoneurons, in addition to the potential for a variety of treatments, different experimental models of axonal injury have been proposed. Recent studies have tested the immunomodulatory drug dimethyl fumarate (DMF) for the treatment of neurodegenerative diseases and have shown promising outcomes. Therefore, in this work, we investigated the effects of DMF with regard to neuroprotection and its influence on the glial response in C57BL/6J animals subjected to crushing of the motor roots in the lumbar intumescence of the spinal cord. The animals were divided into a vehicle-treated injury group (0.08 % methylcellulose solution control group, n = 7) and injured groups treated with DMF at different doses (15, 30, 45, 90 and 180 mg/kg; n = 6-7 per dose). The 90 mg/kg dose showed the best neuroprotective results, so it was used for treatment over a period of eight weeks. Neuronal survival was assessed through Nissl staining, and functional recovery was evaluated with the CatWalk system (walking track test) and the von Frey test (mechanoreception). Immunohistochemistry was used to assess synaptic coverage and astroglial and microglial reactivity using the primary antibodies anti-synaptophysin (pre-synaptic terminal pan marker), GAD65 (GABAergic pre-synaptic terminations - inhibitory), and VGLUT1 (glutamatergic pre-synaptic terminations - excitatory). Glial reactions were evaluated with anti-IBA1 (microglia) and GFAP (astrocytes). Gene transcript levels of IL-3, IL-4, TNF-α, IL-6, TGF-ß, iNOS-M1, and arginase-M2 were quantified by RT-qPCR. The results indicated that treatment with DMF, at a dose of 90 mg/kg, promoted neuroprotection and immunomodulation towards an anti-inflammatory response. It also resulted in greater preservation of inhibitory synapses and reduced astroglial reactivity, providing a more favorable environment for sensorimotor recovery.


Subject(s)
Dimethyl Fumarate/pharmacology , Motor Neurons/drug effects , Nerve Crush , Neuroprotective Agents/pharmacology , Spinal Nerve Roots/injuries , Animals , Cytokines/metabolism , Female , Mice , Motor Neurons/metabolism , Nociception/drug effects , Spinal Nerve Roots/drug effects , Spinal Nerve Roots/metabolism , Synapses/drug effects , Synapses/metabolism
4.
Front Neurol ; 9: 950, 2018.
Article in English | MEDLINE | ID: mdl-30524355

ABSTRACT

Background: Although it has been suggested that healthier lifestyle may optimize effects of the immunomodulation drugs for treating multiple sclerosis (MS), the knowledge regarding this kind of interactions is limited. Objective: The aim of the present study was to investigate the effects of treadmill exercise in combination with pharmacological treatment in an animal model for MS. Methods: C57BL/6J female mice were subjected to daily treadmill exercise for 4 weeks before immunization and 6 weeks before clinical presentation of disease. Dimethyl fumarate (DMF) or glatiramer acetate (GA) were administered after the first clinical relapse. Histopathological analyses were carried out in the lumbar spinal cord at peak disease and at 1 or 14 days post-treatment (dpt). Results: Exercised-GA treated animals demonstrated decreased astrocytic response in the spinal dorsal horn with an improvement in the paw print pressure. Exercised-DMF treated animals showed an increased microglial/macrophage response on both ventral and dorsal horn that were associated with clinical improvement and synaptic motoneuron inputs density. Conclusion: The present data suggest that prior regular exercise can modify the effects of pharmacological treatment administered after the first relapse in a murine model for MS.

5.
BMC Neurol ; 17(1): 160, 2017 Aug 22.
Article in English | MEDLINE | ID: mdl-28830377

ABSTRACT

BACKGROUND: Multiple sclerosis (MS) is a demyelinating disease with a wide range of symptoms including walking impairment and neuropathic pain mainly represented by mechanical allodynia. Noteworthy, exercise preconditioning may affect both walking impairment and mechanical allodynia. Most of MS symptoms can be reproduced in the animal model named experimental autoimmune encephalomyelitis (EAE). Usually, neurological deficits of EAE are recorded using a clinical scale based on the development of disease severity that characterizes tail and limb paralysis. Following paralysis recovery, subtle motor alterations and even mechanical allodynia investigation are difficult to record, representing sequels of peak disease. The aim of the present study was to investigate the walking dysfunction by the catwalk system (CT) in exercised and non-exercised C57BL/6 mice submitted to EAE with MOG35-55 up to 42 days post-induction (dpi). METHODS: Twenty-four C57BL/6 female mice were randomly assigned to unexercised (n = 12) or exercised (n = 12) groups. The MOG35-55 induced EAE model has been performed at the beginning of the fifth week of the physical exercise training protocol. In order to characterize the gait parameters, we used the CT system software version XT 10.1 (Noldus Inc., The Netherlands) from a basal time point (before induction) to 42 days post induction (dpi). Statistical analyses were performed with GraphPad Prisma 4.0 software. RESULTS: Data show dynamic gait changes in EAE mice including differential front (FP) and hind paw (HP) contact latency. Such findings are hypothesized as related to an attempt to maintain balance and posture similar to what has been observed in patients with MS. Importantly, pre-exercised mice show differences in the mentioned gait compensation, particularly at the propulsion sub-phase of HP stand. Besides, we observed reduced intensity of the paw prints as well as reduced print area in EAE subjects, suggestive of a development of chronic mechanical allodynia in spite of being previously exercised. CONCLUSIONS: Our data suggest that Catwalk system is a useful tool to investigate subtle motor impairment and mechanical allodynia at chronic time points of the EAE model, improving the functional investigation of gait abnormalities and demyelination sequelae.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/physiopathology , Multiple Sclerosis/physiopathology , Neuralgia/physiopathology , Animals , Disease Models, Animal , Female , Gait , Hyperalgesia/physiopathology , Male , Mice , Mice, Inbred C57BL , Paralysis/complications
6.
J Neurochem ; 136 Suppl 1: 63-73, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26364732

ABSTRACT

Although previous studies have shown that forced exercise modulates inflammation and is therapeutic acutely for experimental autoimmune encephalomyelitis (EAE), the long-term benefits have not been evaluated. In this study, we investigated the effects of preconditioning exercise on the clinical and pathological progression of EAE. Female C57BL/6 mice were randomly assigned to either an exercised (Ex) or unexercised (UEx) group and all of them were induced for EAE. Mice in the Ex group had an attenuated clinical score relative to UEx mice throughout the study. At 42 dpi, flow cytometry analysis showed a significant reduction in B cells, CD4(+) T cells, and CD8(+) T cells infiltrating into the spinal cord in the Ex group compared to UEx. Ex mice also had a significant reduction in myelin damage with a corresponding increase in proteolipid protein expression. Finally, Ex mice had a significant reduction in axonal damage. Collectively, our study demonstrates for the first time that a prolonged and forced preconditioning protocol of exercise improves clinical outcome and attenuates pathological hallmarks of EAE at chronic disease. In this study, we show that a program of 6 weeks of preconditioning exercise promoted a significant reduction of cells infiltrating into the spinal cord, a significant reduction in myelin damage and a significant reduction in axonal damage in experimental autoimmune encephalomyelitis (EAE) mice at 42 dpi. Collectively, our study demonstrates for the first time that a preconditioning protocol of exercise improves clinical outcome and attenuates pathological hallmarks of EAE at chronic disease.


Subject(s)
Axons/pathology , Encephalomyelitis, Autoimmune, Experimental/pathology , Encephalomyelitis, Autoimmune, Experimental/prevention & control , Physical Conditioning, Animal/physiology , Swimming/physiology , Animals , Demyelinating Autoimmune Diseases, CNS/pathology , Demyelinating Autoimmune Diseases, CNS/prevention & control , Female , Mice , Mice, Inbred C57BL , Physical Conditioning, Animal/methods , Treatment Outcome
7.
Med Biol Eng Comput ; 53(2): 151-63, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25367738

ABSTRACT

Intravital microscopy is an important experimental tool for the study of cellular and molecular mechanisms of the leukocyte-endothelial interactions in the microcirculation of various tissues and in different inflammatory conditions of in vivo specimens. However, due to the limited control over the conditions of the image acquisition, motion blur and artifacts, resulting mainly from the heartbeat and respiratory movements of the in vivo specimen, will very often be present. This problem can significantly undermine the results of either visual or computerized analysis of the acquired video images. Since only a fraction of the total number of images are usually corrupted by severe motion blur, it is necessary to have a procedure to automatically identify such images in the video for either further restoration or removal. This paper proposes a new technique for the detection of motion blur in intravital video microscopy based on directional statistics of local energy maps computed using a bank of 2D log-Gabor filters. Quantitative assessment using both artificially corrupted images and real microscopy data were conducted to test the effectiveness of the proposed method. Results showed an area under the receiver operating characteristic curve (AUC) of 0.95 (AUC = 0.95; 95 % CI 0.93-0.97) when tested on 329 video images visually ranked by four observers.


Subject(s)
Image Processing, Computer-Assisted/methods , Microscopy, Video/methods , Algorithms , Artifacts , Image Enhancement/methods , Motion , ROC Curve
8.
Brain Behav Immun ; 41: 65-81, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24938671

ABSTRACT

Patients suffering from neuropathic pain have a higher incidence of mood disorders such as depression. Increased expression of tumor necrosis factor (TNF) has been reported in neuropathic pain and depressive-like conditions and most of the pro-inflammatory effects of TNF are mediated by the TNF receptor 1 (TNFR1). Here we sought to investigate: (1) the occurrence of depressive-like behavior in chronic neuropathic pain and the associated forms of hippocampal plasticity, and (2) the involvement of TNFR1-mediated TNF signaling as a possible regulator of such events. Neuropathic pain was induced by chronic constriction injury of the sciatic nerve in wild-type and TNFR1(-/-) mice. Anhedonia, weight loss and physical state were measured as symptoms of depression. Hippocampal neurogenesis, neuroplasticity, myelin remodeling and TNF/TNFRs expression were analyzed by immunohistochemical analysis and western blot assay. We found that neuropathic pain resulted in the development of depressive symptoms in a time dependent manner and was associated with profound hippocampal alterations such as impaired neurogenesis, reduced expression of neuroplasticity markers and myelin proteins. The onset of depressive-like behavior also coincided with increased hippocampal levels of TNF, and decreased expression of TNF receptor 2 (TNFR2), which were all fully restored after mice spontaneously recovered from pain. Notably, TNFR1(-/-) mice did not develop depressive-like symptoms after injury, nor were there changes in hippocampal neurogenesis and plasticity. Our data show that neuropathic pain induces a cluster of depressive-like symptoms and profound hippocampal plasticity that are dependent on TNF signaling through TNFR1.


Subject(s)
Depression/etiology , Hippocampus/pathology , Neuralgia/physiopathology , Neurogenesis/physiology , Neuronal Plasticity/physiology , Receptors, Tumor Necrosis Factor, Type I/physiology , Sciatica/physiopathology , Signal Transduction/physiology , Anhedonia/physiology , Animals , Corticosterone/blood , Depression/physiopathology , Drinking Behavior/physiology , Exploratory Behavior/physiology , Food Preferences/physiology , Hot Temperature/adverse effects , Hyperalgesia/etiology , Hyperalgesia/physiopathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Neuralgia/pathology , Neuralgia/psychology , Pressure/adverse effects , Receptors, Tumor Necrosis Factor/biosynthesis , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor, Type I/deficiency , Receptors, Tumor Necrosis Factor, Type I/genetics , Sciatic Nerve/injuries , Sciatica/pathology , Sciatica/psychology , Single-Blind Method , Tumor Necrosis Factor-alpha/physiology
9.
J Neuroimmunol ; 264(1-2): 24-34, 2013 Nov 15.
Article in English | MEDLINE | ID: mdl-24054000

ABSTRACT

The interactions between a prior program of regular exercise and the development of experimental autoimmune encephalomyelitis (EAE)-mediated responses were evaluated. In the exercised EAE mice, although there was no effect on infiltrated cells, the cytokine and derived neurotrophic factor (BDNF) levels were altered, and the clinical score was attenuated. Although, the cytokine levels were decreased in the brain and increased in the spinal cord, BDNF was elevated in both compartments with a tendency of lesser demyelization volume in the spinal cord of the exercised EAE group compared with the unexercised.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Brain/metabolism , Cytokines/metabolism , Encephalomyelitis, Autoimmune, Experimental/pathology , Encephalomyelitis, Autoimmune, Experimental/rehabilitation , Exercise Therapy/methods , Spinal Cord/metabolism , Analysis of Variance , Animals , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Freund's Adjuvant/toxicity , Leukocyte Count , Mice , Mice, Inbred C57BL , Myelin-Oligodendrocyte Glycoprotein/toxicity , Peptide Fragments/toxicity , Physical Conditioning, Animal/methods , Swimming , Time Factors
10.
Microbes Infect ; 15(13): 903-10, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23988520

ABSTRACT

Infection of mice with Plasmodium berghei NK65 represents a well-recognized malaria model in which infection is accompanied by an intense hepatic inflammatory response. Enzyme-inducible nitric oxide synthase is an important regulator of inflammation and leukocyte recruitment in microvessels, but these functions have yet to be evaluated in experimental malaria. In this study, we assessed the involvement of inducible nitric oxide synthase in inflammatory responses to murine experimental malaria induced by P. berghei NK65. We observed that wild type (WT) and nitric oxide synthase (iNOS)-deficient mice (iNOS(-/-)) mice showed similar levels of parasitemia following P. berghei NK65 infection, although infected iNOS(-/-) mice presented early mortality. Inducible nitric oxide synthase deficiency led to increased leukocyte rolling and adhesion to the liver in iNOS(-/-) mice relative to the WT animals, as observed via intravital microscopy. Infected iNOS(-/-) mice also exhibited increased hepatic leukocyte migration and subsequent liver damage, which was associated with high serum levels of the cytokines TNF-α, IL-6 and IL-10. Our data suggest potential role for the iNOS enzyme as a regulator of hepatic inflammatory response induced by P. berghei NK65-infection, and its absence leads to exacerbated inflammation and sequential associated-hepatic damage in the animals.


Subject(s)
Hepatitis/immunology , Hepatitis/parasitology , Malaria/immunology , Nitric Oxide Synthase Type II/immunology , Plasmodium berghei/immunology , Animals , Cytokines/blood , Hepatitis/pathology , Liver/immunology , Liver/pathology , Malaria/pathology , Mice , Mice, Knockout , Nitric Oxide Synthase Type II/deficiency , Plasmodium berghei/pathogenicity , Survival Analysis
11.
J Neurochem ; 123(2): 317-24, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22913494

ABSTRACT

Although it is well known that regular exercise may promote neuroprotection, the mechanisms underlying this effect are still not fully understood. We investigated if swim training promotes neuroprotection by potentiating antioxidant pathways, thereby decreasing the effects of oxidative stress on glutamate and nitric oxide release. Male Wistar rats (n=36) were evenly randomized into a trained group (TRA) (5 days/week, 8 weeks, 30 min) and a sedentary group (SED). Forty-eight hours after the last session of exercise, animals were killed and brain was collected for in vitro ischemia. Cortical slices were divided into two groups: a group in which oxidative stress was induced by oxygen and glucose deprivation (OGD), and a group of non-deprived controls (nOGD). Interestingly, exercise by itself increased superoxide dismutase activity (nOGD, SED vs. TRA animals) with no effect on pro-oxidative markers. In fact, TRA-OGD slices showed lowered levels of lactate dehydrogenase when compared with SED-OGD controls, reinforcing the idea that exercise affords a neuroprotective effect. We also demonstrated that exercise decreased glutamate and nitrite release as well as lipid membrane damage in the OGD cortical slices. Our data suggest that under conditions of metabolic stress, swim training prevents oxidative damage caused by glutamate and nitric oxide release.


Subject(s)
Cerebral Cortex/metabolism , Glucose/metabolism , Oxidative Stress/physiology , Oxygen/metabolism , Physical Conditioning, Animal/physiology , Swimming/physiology , Animals , Cell Hypoxia/physiology , Cerebral Cortex/pathology , Glucose/deficiency , Male , Organ Culture Techniques , Physical Conditioning, Animal/methods , Rats , Rats, Wistar
12.
Rev. bras. educ. fís. esp ; 18(2): 191-200, abr.-jun. 2004. tab, graf
Article in Portuguese | LILACS | ID: lil-496259

ABSTRACT

O objetivo do presente estudo foi avaliar os efeitos interativo e respectivo do treinamento fÍsico moderadode natação e da dieta hiperlipídica sobre o metabolismo de carboidratos e lipídeos no período de recuperação ao exercício em ratos machos adultos. Os animais foram divididos em sedentários (S) e treinados (T). O treinamento consistiu de natação a 90 min/dia, cinco dias/semana. Cada grupo foi subdividido em dieta padrão normocalórica (N) e dieta hipercalórica/hiperlipídica (H). Depois de oito semanas, os animais dos quatro grupos (SN, TN, SH e TH) foram sacrificados em repouso ou uma e duas horas após o exercício. A dieta hipercalórica (grupo SH vs. SN) aumentou o peso dos tecidos adiposos brancos, a glicemia, a concentração plasmática de triglicerídeos e de colesterol total e diminuiu o conteúdo de glicogínio. Por outro lado, o treinamento moderado de natação (grupo TN vs. SN) diminuiu o peso dos tecidos adiposos brancos e melhorou o metabolismo de carboidratos, aumentando o conteúdo de glicogínio. Quando associados (grupo TH vs. SH e TN), o treinamento não foi capaz de reverter os efeitos da dieta para o peso dos tecidos adiposos brancos, conteúdo de glicogínio e glicemia. Com relação ao período de recuperação, concluímos que os efeitos benéficos do treinamento em promover uma rápida recuperação dos substratos endógenos, principalmente reposição de glicogínio, são prejudicados pela dieta hiperlipídica associada ao treinamento.


Subject(s)
Animals , Male , Rats , Diet , Glycogen/metabolism , Lipids , Obesity , Rats, Wistar , Swimming
SELECTION OF CITATIONS
SEARCH DETAIL
...